Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Harbin Pharmaceutical Group Co Ltd (HPGC) is a pharmaceutical company that carries out pharmaceutical manufacturing, trade, and scientific research. The company offers pharmaceutical products, including drugs for chronic diseases, anti-tumor treatments, and cardiovascular medications. The company also offers digestive products, blood and hematopoietic system, anti-tumor and immunomodulatory drugs, anti-inflammatory and analgesic, Chinese medicine, and antibiotics. HPGC manufactures products in therapeutic areas such as anti-infection, cardiovascular and cerebrovascular, cold medicine, digestive system, anti-tumor drugs and nutritional supplements. Its products serve various industries, including healthcare and pharmaceuticals. HPGC is headquartered in Harbin, Heilongjiang, China.
Headquarters
China
Address
No. 7 Qunli Avenue, Harbin, Heilongjiang, 150070
Website
www.hayao.com
Telephone
86 451 51870077
No of Employees
10,039
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
600664 (SHA)
Revenue (2024)
$2.2B
-1.3%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-42.5%
(2024 vs 2023)
Market Cap*
$1.1B
Net Profit Margin (2024)
XYZ
-41.7%
(2024 vs 2023)
* As of and is in US$
Harbin Pharmaceutical Group Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Digestive products | Shiyitang |
| Blood and Hematopoietic System Medications Products | Sanjin |
| Anti-Tumor and Immunomodulatory Drugs | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Harbin Pharmaceutical Group Co Ltd | Huadong Medicine Co Ltd | Shenzhen Neptunus Bioengineering Co Ltd | Guizhou Xinbang Pharmaceutical Co Ltd |
|---|---|---|---|---|
| Headquarters | China | China | China | China |
| City | Harbin | Hangzhou | Shenzhen | Guiyang |
| State/Province | Heilongjiang | Zhejiang | Guangdong | Guizhou |
| No. of Employees | 10,039 | 19,095 | 6,734 | 4,702 |
| Entity Type | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Lu Chuanyou | President; Director | Executive Board | 2023 | 64 |
| Hu Xiaoping | Chairman | Senior Management | 2023 | 56 |
| Meng Xiaodong | Chief Financial Officer; Vice President; Secretary | Senior Management | 2024 | - |
| Yin Shiwei | Director - director | Senior Management | 2022 | 51 |
| Liu Mo | Director - director | Senior Management | 2023 | 48 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer